Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment

NCT07671755 is registered in ClinicalTrials.gov with Shaheed Mohtarma Benazir Bhutto Institue of Trauma as lead sponsor.

NCT NCT07671755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07671755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment
Lead sponsor
Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2025
Completion date
April 30, 2026
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical response, radiological response